Bender James G.

VP, Product Development & Mfg. at ImmunoCellular Therapeutics, Ltd.

Sold, on record
$93k
Dollars the filings state
Form 4 sales
3
Latest Aug 29, 2013
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. May 31, 2012 2012

    Sold 7,000 shares at $3.92 ($27k)

    Bender James G., VP, Product Development & Mfg.

    Sold 47.7% of holdings ($58k position)7,679 shares leftFirst sale on recordFiling

  2. Jun 1, 2012 +1 day

    Sold 7,000 shares at $3.60 ($25k)

    Bender James G., VP Product Development & Mfg.

    Sold 88.8% of holdings ($28k position)879 shares leftFiling

  3. Aug 29, 2013 +454 days

    Sold 14,203 shares at $2.87 ($41k)

    Bender James G., VP, Product Development & Mfg.

    Sold 99.3% of holdings ($41k position)100 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Bender James G.
Source
Aug 29, 2013Aug 30, 2013ImmunoCellular Therapeutics, Ltd.VP, Product Development & Mfg.Form 4 sale14,203$41k99.3%UnusualSEC
Jun 1, 2012Jun 6, 2012ImmunoCellular Therapeutics, Ltd.VP Product Development & Mfg.Form 4 sale7,000$25k88.8%UnusualSEC
May 31, 2012May 31, 2012ImmunoCellular Therapeutics, Ltd.VP, Product Development & Mfg.Form 4 sale7,000$27k47.7%UnusualSEC